Medinex Speciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 12-12-2024
- Paid Up Capital ₹ 75.00 K
as on 12-12-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.10 M
as on 12-12-2024
- Satisfied Charges ₹ 1.09 Cr
as on 12-12-2024
- Revenue -5.23%
(FY 2021)
- Profit 4.98%
(FY 2021)
- Ebitda 7.61%
(FY 2021)
- Net Worth 39.60%
(FY 2021)
- Total Assets 25.36%
(FY 2021)
About Medinex Speciality Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 75.00 K .
The company currently has active open charges totaling ₹0.10 M. The company has closed loans amounting to ₹1.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kirti Thakkar and Nitin Natvarlal serve as directors at the Company.
- CIN/LLPIN
U24119GJ2003PTC042843
- Company No.
042843
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2003
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bhavnagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medinex Speciality Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kirti Thakkar  | Director | 02-Sep-2003 | Current |
| Nitin Natvarlal | Director | 02-Sep-2003 | Current |
Financial Performance of Medinex Speciality Chemicals.
Medinex Speciality Chemicals Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 5.23% decrease. The company also saw a slight improvement in profitability, with a 4.98% increase in profit. The company's net worth Soared by an impressive increase of 39.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medinex Speciality Chemicals?
In 2021, Medinex Speciality Chemicals had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medinex Laboratories Private LimitedActive 52 years 8 monthsKirti Thakkar and Nitin Natvarlal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 May 2023 | ₹0.10 M | Open |
Hdfc Bank Limited Creation Date: 26 Oct 2015 | ₹7.85 M | Satisfied |
State Bank Of India Creation Date: 16 Feb 2004 | ₹3.00 M | Satisfied |
How Many Employees Work at Medinex Speciality Chemicals?
Unlock and access historical data on people associated with Medinex Speciality Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medinex Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medinex Speciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
